Synopsis of research lines:
The Wooldridge group is based in the Faculty of Health Sciences, University of Bristol. Bristol is one of the most popular universities in the UK and was ranked within the top 50 universities in the world in the QS World University rankings 2016. The University has had a reputation for innovation and research since its founding in 1876. The Wooldridge group is located in the Biomedical Sciences building which houses a range of different expertise from immunology, cancer genetics, virology and biochemistry, which provides a very diverse interdisciplinary environment. In addition, the building is well equipped with state of the art technology such as imaging suites and polychromatic flow cytometry facility.
The Wooldridge group currently consists of two postdocs, three fellows and a PhD student. The group specializes in CD8 T cell immunology and uses state of the art technology to examine basic mechanisms of CD8 T cell activation and the role that CD8 T cells play in diseases such as multiple sclerosis and leukemia. In addition the group has a strong in interest in the expansion and engineering of CD8 T cells for cancer immunotherapy.